A randomised double-blind study of the effect of cranberry juice in decreasing the incidence of urinary symptoms and urinary tract infections in patients undergoing pelvic radiotherapy for cancer of bladder or cervix

ISRCTN ISRCTN44646348
DOI https://doi.org/10.1186/ISRCTN44646348
Secondary identifying numbers MI43
Submission date
31/08/2005
Registration date
16/09/2005
Last edited
25/09/2012
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Cancer
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Study website

Contact information

Mrs Cathy Hutchison
Scientific

North Glasgow University Hospitals NHS Trust
Divisional Offices (West)
Western Infirmary
Dumbarton Road
Glasgow
G11 6NT
United Kingdom

Study information

Study designRandomised double blind placebo controlled parallel group trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typePrevention
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study objectivesTo assess whether drinking cranberry juice decreases the incidence of urinary tract infections and urinary side effects
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedBladder or cervix cancer
InterventionCranberry juice or placebo
Intervention typeDrug
Pharmaceutical study type(s)
PhaseNot Specified
Drug / device / biological / vaccine name(s)Cranberry juice or placebo
Primary outcome measureIncrease in Common Toxicity Criteria (CTC) grade of urinary tract symptoms OR development of urinary tract infection
Secondary outcome measuresOther CTC toxicities
Overall study start date24/02/2003
Completion date01/01/2008

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants250
Key inclusion criteria1. Patients with cervical cancer about to start standard chemoradiation (weekly cisplatin chemotherapy plus radiation therapy as below) or radiation therapy (4300-4500 cGy over 20 fractions +/-selectron radiotherapy)
2. OR patients with bladder cancer about to commence standard radical radiotherapy (5000-5240 cGy over 20 fractions).
3. Age ≥ 18 years.
4. ECOG performance status ≤ 2.
5. Written informed consent and the ability to comply with the requirements of the study.
Key exclusion criteria1. Pregnant or lactating women are excluded. Female patients of child-bearing potential are eligible provided they have a negative urine pregnancy test prior to enrolment and agree to use approved contraceptive precautions during the trial and for 6 months afterwards.
2. Patients with irritable bowel syndrome (they may experience episodes of diarrhoea as a side effect of drinking cranberry juice).
3. Patients who are diabetic (due to the high sugar content of the juice).
4. Patients who have rheumatoid arthritis (the acidic juices may exacerbate joint pain).
5. Patients with urinary symptoms or urinary tract infections at baseline.
6. Patients receiving antispasmodics or antibiotics for urinary symptoms.
7. Patients with an indwelling urinary catheter.
Date of first enrolment24/02/2003
Date of final enrolment01/01/2008

Locations

Countries of recruitment

  • Scotland
  • United Kingdom

Study participating centre

North Glasgow University Hospitals NHS Trust
Glasgow
G11 6NT
United Kingdom

Sponsor information

Greater Glasgow NHS Board, North Glasgow Division (UK)
Hospital/treatment centre

West Research Office
Administration Building
Western Infirmary
Glasgow
G11 6NT
Scotland
United Kingdom

Website http://www.ngt.org.uk/research/home.htm
ROR logo "ROR" https://ror.org/05kdz4d87

Funders

Funder type

Charity

Western Endowment Fund (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/03/2012 Yes No